177 related articles for article (PubMed ID: 12874093)
1. Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats.
Hoagland KM; Flasch AK; Roman RJ
Hypertension; 2003 Oct; 42(4):669-73. PubMed ID: 12874093
[TBL] [Abstract][Full Text] [Related]
2. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II.
Alonso-Galicia M; Maier KG; Greene AS; Cowley AW; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R60-8. PubMed ID: 12069931
[TBL] [Abstract][Full Text] [Related]
3. Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresis.
Williams JM; Sarkis A; Lopez B; Ryan RP; Flasch AK; Roman RJ
Hypertension; 2007 Mar; 49(3):687-94. PubMed ID: 17210834
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of 20-hydroxyeicosatetraenoic acid (20-HETE) formation attenuate the natriuretic effect of dopamine.
Fernandez MM; Gonzalez D; Williams JM; Roman RJ; Nowicki S
Eur J Pharmacol; 2012 Jul; 686(1-3):97-103. PubMed ID: 22575524
[TBL] [Abstract][Full Text] [Related]
5. Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.
Yousif MH; Benter IF; Dunn KM; Dahly-Vernon AJ; Akhtar S; Roman RJ
Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):1-12. PubMed ID: 19302551
[TBL] [Abstract][Full Text] [Related]
6. The role of 20-hydroxyeicosatetraenoic acid in adrenocorticotrophic hormone and dexamethasone-induced hypertension.
Zhang Y; Wu JH; Vickers JJ; Ong SL; Temple SE; Mori TA; Croft KD; Whitworth JA
J Hypertens; 2009 Aug; 27(8):1609-16. PubMed ID: 19458537
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P-450 monooxygenases in control of renal haemodynamics and arterial pressure in anaesthetized rats.
Kuczeriszka M; Badzyńska B; Kompanowska-Jezierska E
J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():179-85. PubMed ID: 17244949
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the formation of EETs and 20-HETE with 1-aminobenzotriazole attenuates pressure natriuresis.
Dos Santos EA; Dahly-Vernon AJ; Hoagland KM; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2004 Jul; 287(1):R58-68. PubMed ID: 15031141
[TBL] [Abstract][Full Text] [Related]
9. Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats.
Hoagland KM; Maier KG; Roman RJ
Hypertension; 2003 Mar; 41(3 Pt 2):697-702. PubMed ID: 12623982
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR.
Su P; Kaushal KM; Kroetz DL
Am J Physiol; 1998 Aug; 275(2):R426-38. PubMed ID: 9688677
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension.
Oyekan AO; McAward K; Conetta J; Rosenfeld L; McGiff JC
Am J Physiol; 1999 Mar; 276(3):R766-75. PubMed ID: 10070137
[TBL] [Abstract][Full Text] [Related]
12. HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme.
Miyata N; Taniguchi K; Seki T; Ishimoto T; Sato-Watanabe M; Yasuda Y; Doi M; Kametani S; Tomishima Y; Ueki T; Sato M; Kameo K
Br J Pharmacol; 2001 Jun; 133(3):325-9. PubMed ID: 11375247
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus.
Sarkis A; Ito O; Mori T; Kohzuki M; Ito S; Verbalis J; Cowley AW; Roman RJ
Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1333-40. PubMed ID: 16014574
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 4A isoform inhibitory profile of N-hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine (HET0016), a selective inhibitor of 20-HETE synthesis.
Seki T; Wang MH; Miyata N; Laniado-Schwartzman M
Biol Pharm Bull; 2005 Sep; 28(9):1651-4. PubMed ID: 16141533
[TBL] [Abstract][Full Text] [Related]
15. Intravenous formulation of N-hydroxy-N'-(4-n-butyl-2-methylphenyl)formamidine (HET0016) for inhibition of rat brain 20-hydroxyeicosatetraenoic acid formation.
Mu Y; Klamerus MM; Miller TM; Rohan LC; Graham SH; Poloyac SM
Drug Metab Dispos; 2008 Nov; 36(11):2324-30. PubMed ID: 18725506
[TBL] [Abstract][Full Text] [Related]
16. High salt intake increases blood pressure in normal rats: putative role of 20-HETE and no evidence on changes in renal vascular reactivity.
Walkowska A; Kuczeriszka M; Sadowski J; Olszyñski KH; Dobrowolski L; Červenka L; Hammock BD; Kompanowska-Jezierska E
Kidney Blood Press Res; 2015; 40(3):323-34. PubMed ID: 26067851
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats.
Chábová VC; Kramer HJ; Vanecková I; Vernerová Z; Eis V; Tesar V; Skaroupková P; Thumová M; Schejbalová S; Husková Z; Vanourková Z; Kolský A; Imig JD; Cervenka L
Vascul Pharmacol; 2007; 47(2-3):145-59. PubMed ID: 17604232
[TBL] [Abstract][Full Text] [Related]
18. Renal 20-hydroxyeicosatetraenoic acid synthesis during pregnancy.
Wang MH; Zand BA; Nasjletti A; Laniado-Schwartzman M
Am J Physiol Regul Integr Comp Physiol; 2002 Feb; 282(2):R383-9. PubMed ID: 11792647
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of renal outer medullary 20-HETE production produces hypertension in Lewis rats.
Stec DE; Mattson DL; Roman RJ
Hypertension; 1997 Jan; 29(1 Pt 2):315-9. PubMed ID: 9039121
[TBL] [Abstract][Full Text] [Related]
20. Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier.
Williams JM; Sharma M; Anjaiahh S; Falck JR; Roman RJ
Am J Physiol Renal Physiol; 2007 Aug; 293(2):F501-5. PubMed ID: 17507602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
